ML Fahrni, IAN Ismail, DM Refi… - … policy and practice, 2022 - Taylor & Francis
Background Successful mass vaccination programmes are public health achievements of the contemporary world. While pharmaceutical companies are actively developing new …
KGM Danabal, SS Magesh, S Saravanan… - BMC Health Services …, 2021 - Springer
Background Effective and safe COVID 19 vaccines have been approved for emergency use since the end of 2020 and countries are actively vaccinating their people. Nevertheless …
J Jain, S Saurabh, P Kumar, MK Verma… - Epidemiology & …, 2021 - cambridge.org
The coronavirus disease 2019 (COVID-19) vaccine was launched in India on 16 January 2021, prioritising health care workers which included medical students. We aimed to assess …
S Umakanthan, S Patil, N Subramaniam, R Sharma - Vaccines, 2021 - mdpi.com
Background: The World Health Organization has recommended that individual governments identify vaccine hesitancy areas. It is proposed that the governments, with the aid of local …
The coronavirus disease (COVID-19) breakout had an unimaginable worldwide effect in the 21st century, claiming millions of lives and putting a huge burden on the global economy …
S Chandani, D Jani, PK Sahu, U Kataria… - Brain, behavior, & …, 2021 - Elsevier
Background Few COVID-19 vaccines were anticipated in India in early 2021. However, little was known about COVID-19 vaccination acceptance among the public. We conducted a …
S Das, SS Kar, S Samanta, J Banerjee, B Giri… - Immunologic …, 2022 - Springer
SARS-CoV-2 is an RNA virus that was identified for the first time in December 2019 in Wuhan, China. The World Health Organization (WHO) labeled the novel coronavirus …
F Chirico, JAT da Silva, P Tsigaris… - Indian Journal of …, 2022 - journals.lww.com
There are currently eight vaccines against SARS-CoV-2 that have received Emergency Use Authorization by the WHO that can offer some protection to the world's population during the …
U Kaur, B Ojha, BK Pathak, A Singh, KR Giri… - …, 2021 - thelancet.com
Background We provide the first post-approval safety analysis of COVISHIELD in health care workers (HCWs) in northern India. Methods This continuing prospective observational study …